Does REGORAFENIB Cause Hyperammonaemic encephalopathy? 10 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Hyperammonaemic encephalopathy have been filed in association with REGORAFENIB (Stivarga). This represents 0.1% of all adverse event reports for REGORAFENIB.
10
Reports of Hyperammonaemic encephalopathy with REGORAFENIB
0.1%
of all REGORAFENIB reports
4
Deaths
9
Hospitalizations
How Dangerous Is Hyperammonaemic encephalopathy From REGORAFENIB?
Of the 10 reports, 4 (40.0%) resulted in death, 9 (90.0%) required hospitalization.
Is Hyperammonaemic encephalopathy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for REGORAFENIB. However, 10 reports have been filed with the FAERS database.
What Other Side Effects Does REGORAFENIB Cause?
Off label use (1,906)
Fatigue (1,530)
Palmar-plantar erythrodysaesthesia syndrome (1,230)
Diarrhoea (1,221)
Decreased appetite (941)
Asthenia (825)
Death (813)
Dysphonia (702)
Nausea (688)
Pain in extremity (686)
What Other Drugs Cause Hyperammonaemic encephalopathy?
VALPROIC ACID (455)
FLUOROURACIL (156)
VALPROATE (120)
DIVALPROEX (119)
OXALIPLATIN (107)
TOPIRAMATE (101)
RISPERIDONE (96)
QUETIAPINE (91)
LEVETIRACETAM (71)
LEUCOVORIN (62)
Which REGORAFENIB Alternatives Have Lower Hyperammonaemic encephalopathy Risk?
REGORAFENIB vs REGORAFENIB\REGORAFENIB
REGORAFENIB vs RELATLIMAB
REGORAFENIB vs RELPAX
REGORAFENIB vs RELUGOLIX
REGORAFENIB vs REMDESIVIR